SOUTH SAN FRANCISCO, Calif., Dec. 6, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the launch of the Make Your Mark at the Multiple Myeloma Experience at the 54 th ...
With CARiD, Onyx has developed a distinctive proprietary technology platform for digital commerce and fulfillment, relying on insights extracted from nearly 14 billion data points, a physical ...
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today reported its financial results for the second quarter 2013 and provided a business update on Kyprolis ® (carfilzomib) for Injection, Nexavar ® ...
SOUTH SAN FRANCISCO, CA--(Marketwired - Jun 30, 2013) - Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today confirmed that it has received and rejected an unsolicited proposal from Amgen Inc. to acquire ...
NEW YORK & CRANBURY, N.J.--(BUSINESS WIRE)--Legacy Acquisition Corp. (NYSE: “LGC”) (“Legacy”), a publicly-traded special purpose acquisition company, and Onyx ...
Welcome to the Onyx Pharmaceuticals Third Quarter 2012 Financial Results Conference Call. My name is Anthony, and I will be your operator for today's call. [Operator Instructions] Later, we will ...
REDMOND, Wash., Aug. 27, 2001 — Onyx Software Corp. and Microsoft Corp. today announced that Onyx is the first customer relationship management applications vendor to pass the certification program ...
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today confirmed that it has received and rejected an unsolicited proposal from Amgen Inc. to acquire all of Onyx's outstanding shares and share equivalents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback